Search
Werewolf Therapeutics Inc
HOWLAdd to Watchlist
0.985USD
-0.004-0.40%
Market hours 09/24, 09:51（ET）
47.87MMarket Cap
LossP/E TTM
Werewolf Therapeutics Inc (HOWL) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Werewolf Therapeutics Inc in the past month.
Hold
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
5.500USD+460.08%
HOWL Analyst Recommendation Trends
In the current month, HOWL has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HOWL average Analyst price target in the last month is 5.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
2
2
2
3
3
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
4
4
4
5
6
6
HOWL Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, HOWL EPS is projected to reach -0.200 in FY2026Q3, following reported EPS of 0.076 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.34
-0.28
-0.26
-0.20
-0.17
Actual
-0.17
-0.28
0.08
--
--
Surprise
+49.86%
+2.30%
+129.05%
--
--
FAQs
What is Werewolf Therapeutics Inc's price target?
Analysts forecast that Werewolf Therapeutics Inc's price target is USD 5.50, with the highest forecast at USD 7.00 and the lowest forecast at USD 4.00.
How have Werewolf Therapeutics IncHOWL's recent earnings per share performed?
The market expectation was USD 0.08, while Werewolf Therapeutics IncHOWL's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Werewolf Therapeutics Inc?
Based on the ratings of Werewolf Therapeutics Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.